Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2006; Volume 186, Supplement 650
Joint Meeting of The German Society of Physiology and The Federation of European Physiological Societies 2006
3/26/2006-3/29/2006
Ludwig-Maximilians-University, Munich


TRANSIENT HYPOXIA PROTECTS ENDOTHELIAL CELLS FROM APOPTOSIS BY MEK/ERK-MEDIATED BAD PHOSPHORYLATION
Abstract number: OM02-11

Holl1 M, Arshad1 M, Aslam1 M, Hartel1 FV, Piper1 HM, Noll1 T

1Physiologisches Institut, Justus-Liebig-Universitt, Giessen

Transient hypoxia can prevent apoptotic death in human endothelial cells from different origins. Here the molecular mechanism of this protective effect is analysed. Apoptosis was induced in HUVEC by either serum deprivation or TNFa (20 ng/ml) for 24 hours. Afterwards cells were exposed to hypoxia (2h, Po2<10 mmHg) followed by reoxygenation for 24 hours (Po2=140 mmHg). Serum deprivation reduced cell number to 47%. Within this population 52% of the cells were apoptotic (Annexin V staining, FACS). In contrast, transient hypoxia reduced cell number to only 74%, and decreased apoptosis to 26% of the surviving cell population. Transient hypoxia had similar effects on TNFa-induced apoptosis. Hypoxia induced activation of ERK1/2 (Western blot). Inhibition of ERK 1/2 by antisense oligonucleotides against ERK 1/2 abolished the effect of transient hypoxia on apoptotic cell death. Transient hypoxia induced phosphorylation of the pro-apoptotic Bad at serine 112 (Western blot), a specific phosphorylation site of ERK 1/2 leading to its inactivation. Moreover, it reduced cytochrome C release from mitochondria (cell fractionation) and caspase 3 activation (Western blot) induced by serum deprivation. Inhibition of ERK 1/2 abolished the effect of hypoxia on all three parameters. Conclusion: Transient hypoxia protects endothelial cells from apoptotic execution by an ERK 1/2-dependent signalling mechanism targeting Bad, Cytochrome C and Caspase 3.

To cite this abstract, please use the following information:
Acta Physiologica 2006; Volume 186, Supplement 650 :OM02-11

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE